2022 Announcements

Notification regarding unquoted securities

2022 Announcements . Financial . Regulatory

06.05.2022

Positive final results in stroke

2022 Announcements . Clinical . News

04.05.2022

CEO letter

2022 Announcements . Financial

29.04.2022

Appendix 4C & Activity Report

2022 Announcements . Financial . Regulatory

28.04.2022

Notice of ceasing to be a substantial holder

2022 Announcements . Financial . Regulatory

27.04.2022

CLINUVEL Kommuniqué II

2022 Announcements . Corporate . Newsletter

08.04.2022

Initial Director’s Interest Notice

2022 Announcements . Financial . Regulatory

07.04.2022

Chair’s Letter

2022 Announcements . Corporate

06.04.2022

CLINUVEL appoints new Non-Executive Director

2022 Announcements . Financial . Regulatory

04.04.2022

CLINUVEL Extends Employment Agreement With CEO

2022 Announcements . Clinical . News

01.04.2022

DNA Repair Communiqué II

2022 Announcements . Clinical . Newsletter

01.04.2022

CLINUVEL Communiqué II

2022 Announcements . Corporate . Newsletter

31.03.2022

First XP-V Patient Treated in CLINUVEL DNA Repair Study

2022 Announcements . Clinical . News

30.03.2022

.

Go To Top